enGene (ENGNW) Expected to Announce Quarterly Earnings on Monday

enGene (NASDAQ:ENGNW) will likely be announcing its resultson Monday, March 16th. Analysts expect the company to announce earnings of ($0.5596) per share for the quarter.

enGene Stock Down 7.7%

Shares of ENGNW stock opened at $3.00 on Monday. The stock’s 50-day moving average is $3.16 and its 200 day moving average is $2.25. enGene has a 1-year low of $0.51 and a 1-year high of $4.20.

About enGene

enGene Holdings Inc, through its subsidiary enGene, Inc, operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.